These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22824982)

  • 1. Observational study mortality in treated primary aldosteronism: the German Conn's registry.
    Reincke M; Fischer E; Gerum S; Merkle K; Schulz S; Pallauf A; Quinkler M; Hanslik G; Lang K; Hahner S; Allolio B; Meisinger C; Holle R; Beuschlein F; Bidlingmaier M; Endres S;
    Hypertension; 2012 Sep; 60(3):618-24. PubMed ID: 22824982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry.
    Reincke M; Meisinger C; Holle R; Quinkler M; Hahner S; Beuschlein F; Bidlingmaier M; Seissler J; Endres S;
    Horm Metab Res; 2010 Jun; 42(6):435-9. PubMed ID: 20119885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.
    Born-Frontsberg E; Reincke M; Rump LC; Hahner S; Diederich S; Lorenz R; Allolio B; Seufert J; Schirpenbach C; Beuschlein F; Bidlingmaier M; Endres S; Quinkler M;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1125-30. PubMed ID: 19190103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry.
    Hanslik G; Wallaschofski H; Dietz A; Riester A; Reincke M; Allolio B; Lang K; Quack I; Rump LC; Willenberg HS; Beuschlein F; Quinkler M; Hannemann A;
    Eur J Endocrinol; 2015 Nov; 173(5):665-75. PubMed ID: 26311088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.
    Grotevendt A; Wallaschofski H; Reincke M; Adolf C; Quinkler M; Nauck M; Hoffmann W; Rettig R; Hannemann A
    Endocrine; 2017 Aug; 57(2):298-307. PubMed ID: 28638984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism.
    Remde H; Dietz A; Emeny R; Riester A; Peters A; de Las Heras Gala T; Then C; Seissler J; Beuschlein F; Reincke M; Quinkler M
    J Hypertens; 2016 Oct; 34(10):2066-73. PubMed ID: 27442789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with a low glomerular filtration rate in primary aldosteronism.
    Reincke M; Rump LC; Quinkler M; Hahner S; Diederich S; Lorenz R; Seufert J; Schirpenbach C; Beuschlein F; Bidlingmaier M; Meisinger C; Holle R; Endres S;
    J Clin Endocrinol Metab; 2009 Mar; 94(3):869-75. PubMed ID: 19116235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism - Findings From the German Conn's Registry.
    Asbach E; Bekeran M; König A; Lang K; Hanslik G; Treitl M; Ladurner R; Bidlingmaier M; Beuschlein F; Quinkler M; Reincke M
    Exp Clin Endocrinol Diabetes; 2020 Apr; 128(4):246-254. PubMed ID: 31698477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry.
    Schirpenbach C; Segmiller F; Diederich S; Hahner S; Lorenz R; Rump LC; Seufert J; Quinkler M; Bidlingmaier M; Beuschlein F; Endres S; Reincke M
    Dtsch Arztebl Int; 2009 May; 106(18):305-11. PubMed ID: 19547646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.
    Ohno Y; Sone M; Inagaki N; Yamasaki T; Ogawa O; Takeda Y; Kurihara I; Itoh H; Umakoshi H; Tsuiki M; Ichijo T; Katabami T; Tanaka Y; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Okamura S; Miyauchi S; Fukuoka T; Izawa S; Yoneda T; Hashimoto S; Yanase T; Suzuki T; Kawamura T; Tabara Y; Matsuda F; Naruse M; ;
    Hypertension; 2018 Mar; 71(3):530-537. PubMed ID: 29358460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms.
    Heinrich DA; Adolf C; Rump LC; Quack I; Quinkler M; Hahner S; Januszewicz A; Seufert J; Willenberg HS; Nirschl N; Sturm L; Beuschlein F; Reincke M
    Eur J Endocrinol; 2018 Jun; 178(6):605-611. PubMed ID: 29636356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry.
    Fischer E; Reuschl S; Quinkler M; Rump LC; Hahner S; Bidlingmaier M; Reincke M;
    Horm Metab Res; 2013 Jul; 45(7):526-31. PubMed ID: 23613013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism.
    Riester A; Fischer E; Degenhart C; Reiser MF; Bidlingmaier M; Beuschlein F; Reincke M; Quinkler M
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1035-9. PubMed ID: 24601689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA?
    Baguet JP; Steichen O; Mounier-Véhier C; Gosse P
    Ann Endocrinol (Paris); 2016 Jul; 77(3):187-91. PubMed ID: 27087531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: A Meta-analysis.
    Jing Y; Liao K; Li R; Yang S; Song Y; He W; Wang K; Yang J; Li Q; Hu J
    J Renin Angiotensin Aldosterone Syst; 2021; 22(1):14703203211003781. PubMed ID: 33752505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Primary Aldosteronism in Patients with Hypokalemia (IPAHK+): Study Design and Baseline Characteristics.
    Gruber S; Stasi E; Steiner R; Reincke M; Bornstein S; Beuschlein F
    Horm Metab Res; 2021 Dec; 53(12):787-793. PubMed ID: 34891208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study.
    Wu VC; Chang CH; Wang CY; Lin YH; Kao TW; Lin PC; Chu TS; Chang YS; Chen L; Wu KD; Chueh SJ
    J Bone Miner Res; 2017 Apr; 32(4):743-752. PubMed ID: 27862274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess Mortality among Persons with Type 2 Diabetes.
    Tancredi M; Rosengren A; Svensson AM; Kosiborod M; Pivodic A; Gudbjörnsdottir S; Wedel H; Clements M; Dahlqvist S; Lind M
    N Engl J Med; 2015 Oct; 373(18):1720-32. PubMed ID: 26510021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
    Markou A; Pappa T; Kaltsas G; Gouli A; Mitsakis K; Tsounas P; Prevoli A; Tsiavos V; Papanastasiou L; Zografos G; Chrousos GP; Piaditis GP
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1409-16. PubMed ID: 23471976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.
    Künzel HE; Apostolopoulou K; Pallauf A; Gerum S; Merkle K; Schulz S; Fischer E; Brand V; Bidlingmaier M; Endres S; Beuschlein F; Reincke M
    J Psychiatr Res; 2012 Dec; 46(12):1650-4. PubMed ID: 23017810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.